| For: | Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of | 
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i16/5032.htm | 
| Number | Citing Articles | 
| 1 | 
                                            Javaria Amil, Saadia Sajjad, Rida Ajmal Khan, Sadia Majeed, Khalil Ahmed, Muhammad Adnan Masood. Comparison of Therapeutic Outcomes: Two Triple-Therapy Approaches for H. pylori Eradication in Gastric Ulcer Disease. Pakistan Journal of Health Sciences 2024; : 142 doi: 10.54393/pjhs.v5i07.1850
                                         | 
| 2 | 
                                            Yoon Suk Jung, Chan Hyuk Park, Jung Ho Park, Eunwoo Nam, Hang Lak Lee. Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta‐analysis. Helicobacter 2017; 22(4) doi: 10.1111/hel.12389
                                         | 
| 3 | 
                                            Soohoon Kwon, Dong Ho Lee, Jae Bin Kang, Nayoung Kim, Young Soo Park, Cheol Min Shin, Hyuk Yoon, Yoon Jin Choi. The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure inHelicobacter pyloriEradication. The Korean Journal of Gastroenterology 2018; 71(4): 196 doi: 10.4166/kjg.2018.71.4.196
                                         | 
| 4 | 
                                            Sumaira Khadim, Iyad Naeem Muhammad, Tanveer Alam, Shahnaz Usman, Hina Rehman, Sajjad Haider. Predictors of Successful First-Line Helicobacter pylori Eradication with Fluoroquinolones in Pakistan: A Prospective Exploration of Demographic and Clinical Factors. Antibiotics 2024; 13(3): 211 doi: 10.3390/antibiotics13030211
                                         | 
| 5 | 
                                            Amro M. Hassan, Khaled Eid, Khaled A.M. Eliwa, Muhammad Abdel-Gawad. Two nitazoxanide-based quadruple regimens for eradication of Helicobacter pylori infection. Al-Azhar Assiut Medical Journal 2022; 20(1): 67 doi: 10.4103/azmj.azmj_74_21
                                         | 
| 6 | 
                                            Jong Yeul Lee, Ji Yong Ahn, Il Ju Choi. Historical Perspective ofHelicobacter pyloriTreatment in Korea. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(4): 211 doi: 10.7704/kjhugr.2015.15.4.211
                                         | 
| 7 | 
                                            Chan Hyuk Park. The first-line regimens of Helicobacter pylori eradication in Korea. Hanyang Medical Reviews 2017; 37(1): 2 doi: 10.7599/hmr.2017.37.1.2
                                         | 
| 8 | 
                                            Sumaira Khadim, Iyad Muhammad Naeem, Muhammad Tanveer Alam, Hina Rehman, Sidra Ghayas, Sajjad Haider. The efficacy of moxifloxacin-based triple-therapy in first-line treatment of Helicobacter pylori infection in Pakistan: randomized controlled trials. Archives of Medical Science – Civilization Diseases 2023; 8(1): 31 doi: 10.5114/amscd.2023.131926
                                         | 
| 9 | 
                                            Jae Jin Hwang, Dong Ho Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim. Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line <italic>Helicobacter pylori</italic> eradication. World Journal of Gastroenterology 2015; 21(35): 10234-10241 doi: 10.3748/wjg.v21.i35.10234
                                         | 
| 10 | 
                                            Jae Yong Park, Jae Gyu Kim. NewHelicobacter pyloriEradication Therapies. The Korean Journal of Gastroenterology 2018; 72(5): 237 doi: 10.4166/kjg.2018.72.5.237
                                         | 

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        